-The Indian Express Chennai: The fate of Sterlite Industries, and that of thousands of people of coastal Tuticorin, now depends on the south bench of the National Green Tribunal, which is hearing the company's petition against its closure ordered by the Tamil Nadu Pollution Control Board (TNPCB). The biggest copper smelting unit in the country, part of the Vedanta Group, moved the tribunal after the TNPCB ordered closure of the plant following...
More »SEARCH RESULT
Total Matching Records found : 11178
Gujarat Bill ending role of Governor, CJ to choose ombudsman passed-Darshan Desai
-The Hindu Amid protests and a walkout by Opposition MLAs in the Assembly, the ruling Bharatiya Janata Party on Tuesday pushed through a new Gujarat Lokayukta Aayog Bill, 2013 that ostensibly seeks to end the role of the Governor and the Chief Justice of the High Court in appointing the ombudsman. The Bill proposes a seven-member selection panel headed by the Chief Minister, which will recommend a candidate for the Lokayukta's post...
More »SC’s Glivec ruling setback to foreign pharma firms -Vidya Krishnan and CH Unnikrishnan
-Live Mint SC rejects Novartis's patent plea for Glivec, says it does not meet any standard of novelty or inventiveness In a landmark judgement, India's apex court rejected Swiss drug maker Novartis AG's legal challenge aimed at securing a patent for blockbuster anti-cancer drug imatinib mesylate, branded Glivec in the country. The verdict, which is seen as a setback to multinational pharmaceutical companies operating in India, may influence a rash of pending disputes...
More »Supreme Court's Glivec ruling will ruin innovation
-The Economic Times Extension of life is priceless. Simply priceless." These were the words of Venkat Krishnan (name changed) to Novartis after receiving treatment with Glivec for about two years. Following his diagnosis with chronic myeloid leukaemia (CML), Venkat married his college sweetheart against the wishes of her family. After all, the prognosis in those days for people suffering from CML was not promising. Taking interferon, a powerful immune therapy, was the...
More »Domestic pharma lauds apex court verdict-Reghu Balakrishnan
-The Business Standard Patients' lobbies cheer ruling on anti-cancer drug Glivec, as affordability and access to life-saving drugs get a leg-up Though the India office here of Swiss pharma giant Novartis wore a gloomy look following the Supreme Court rejection of its Glivec patent application, Indian pharmaceutical companies and patients' associations are in celebration mood. D G Shah, secretary general, The Indian Pharmaceutical Alliance (IPA), comprising Leading research-based Indian pharma companies, said,...
More »
